Courtesy of Benzinga.
Pfizer Inc (NYSE: PFE) reported a drop in its fourth-quarter profit.
Pfizer’s quarterly profit declined to $1.44 billion, or $0.19 per share, from $2.89 billion, or $0.36 per share, in the year-ago period. Its sales fell to $16.75 billion from $17.35 billion. Pfizer’s adjusted earnings came in at $0.50 per share. However, analysts were expecting a profit of $0.47 per share on sales of $16.61 billion.
Pfizer cut its full-year 2012 earnings forecast to between $2.20 and $2.30 per share, versus analysts’ estimates of $2.28 per share.
Pfizer shares gained 1.34% to $21.87 in pre-market trading.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.
